Colosplenic fistula in a patient treated with interleukin-2 for malignant melanoma

被引：7
作者：
Chun, ES
Demos, TC
Gaynor, ER
机构：
[1] LOYOLA UNIV,MED CTR,DEPT RADIOL,MAYWOOD,IL 60153
[2] LOYOLA UNIV,MED CTR,DEPT HEMATOL ONCOL,MAYWOOD,IL 60153
来源：
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY | 1997年 / 21卷 / 04期
关键词：
gastrointestinal fistula; interleukin-2; computed tomography; colon; spleen;
D O I：
10.1097/00004728-199707000-00031
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Interleukin-2 (IL-2) therapy often causes gastrointestinal side effects and at least 8 cases of bowel perforation have been reported. The patient reported here developed a colosplenic fistula, diagnosed by CT, with no neoplastic involvement of these organs. Awareness of these complications of IL-2 can help lead to earlier diagnosis.
引用
收藏
页码：674 / 676
页数：3
相关论文
共 9 条
  • [1] A PHASE-III STUDY OF RECOMBINANT INTERLEUKIN-2 AND 5-FLUOROURACIL CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    HAMBLIN, TJ
    SADULLAH, S
    WILLIAMSON, P
    STEVENSON, J
    OSKAM, R
    PALMER, P
    FRANKS, CR
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1186 - 1189
  • [2] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES
    MARGOLIN, KA
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    DUTCHER, JP
    FISHER, RI
    WEISS, GR
    DOROSHOW, JH
    JAFFE, HS
    ROPER, M
    PARKINSON, DR
    WIERNIK, PH
    CREEKMORE, SP
    BOLDT, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 486 - 498
  • [3] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    [J]. PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [4] UNUSUAL GASTROINTESTINAL COMPLICATIONS OF INTERLEUKIN-2 THERAPY
    RAHMAN, R
    BERNSTEIN, Z
    VAICKUS, L
    PENETRANTE, R
    ARBUCK, S
    KOPEC, I
    VESPER, D
    DOUGLASS, HO
    FOON, KA
    [J]. JOURNAL OF IMMUNOTHERAPY, 1991, 10 (03): : 221 - 225
  • [5] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    CHANG, AE
    AVIS, FP
    LEITMAN, S
    LINEHAN, WM
    ROBERTSON, CN
    LEE, RE
    RUBIN, JT
    SEIPP, CA
    SIMPSON, CG
    WHITE, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) : 889 - 897
  • [6] NEW APPROACHES TO THE IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2
    ROSENBERG, SA
    LOTZE, MT
    MULE, JJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (06) : 853 - 864
  • [7] SCHWARTZENTRUBER D, 1988, CANCER, V62, P2350, DOI 10.1002/1097-0142(19881201)62:11<2350::AID-CNCR2820621116>3.0.CO
  • [8] 2-S
  • [9] EMERGENCY LAPAROTOMY FOR SPONTANEOUS INTESTINAL AND COLONIC PERFORATIONS IN CANCER-PATIENTS RECEIVING CORTICOSTEROIDS AND CHEMOTHERAPY
    TOROSIAN, MH
    TURNBULL, ADM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (02) : 291 - 296
1